Charleston, SC -- (SBWIRE) -- 08/23/2013 -- ImpressivePennyStocks.com covers several stocks on the NASDAQ and New York Stock Exchange that technically qualify as penny stocks, we typically find ones that are on the OTC Market. ImpressivePennyStocks.com issues a special report on the following stocks: Generex Biotechnology Corporation(OTCMKTS:GNBT), Crocs, Inc.(NASDAQ:CROX), Dendreon Corporation(NASDAQ:DNDN), DiamondRock Hospitality Company(NYSE:DRH)
Generex Biotechnology Corporation(OTCMKTS:GNBT) opened its shares at the price of $0.03 for the day. Its closing price was $0.0350. The company traded with the total volume of 2.02 million shares, while its average trading volume remained 3.13 million shares. The beta of GNBT stands at 1.90. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity.
Is GNBT a Solid Investment at These Levels? Read This Report For Details
Crocs, Inc.(NASDAQ:CROX) percentage change surged +1.89% to close at $14.01 with the total traded volume of 2.00 million shares, less than average volume of 2.15 million. The 52 week range of the stock remained $12.00 - $18.60, while its day lowest price was $13.66 and it hit its day highest price at $14.35. Crocs, Inc is a designer, manufacturer and distributor of footwear and accessories for men, women and children. The Active product offering includes sport inspired products and footwear suited for activities, such as boating, walking, hiking and even recovery after workouts.
For How Long CROX will fight for Profitability? Read This Trend Analysis report
Dendreon Corporation (NASDAQ:DNDN) remained among the day advancers and traded with volume of 1.97 million shares in the last session, as compared to average volume 4.81 million shares. Then 52 week range of the stock remained $3.10 - $7.22, while its day lowest price was $3.15 and it hit its day highest price at $3.24. DNDN’s total market capitalization is $503.08 million, along with 157.70 million shares outstanding. Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may significantly improve cancer treatment options for patients. The Company owns worldwide rights for PROVENGE.
Will DNDN Continue To Move Higher? Find Out Here
DiamondRock Hospitality Company(NYSE:DRH) started its trading session with the price of $9.97 and closed at $10.15 by scoring +2.01%. DRH’s stocks traded with total volume of 1.94 million shares, while the average trading volume remained 1.87 million shares. The beta of DRH stands at 2.21. Day range of the stock was $9.91 -$10.19. DiamondRock Hospitality Company is a lodging-focused Maryland corporation operating as a real estate investment trust (REIT). It owns a portfolio of 27 premium hotels and resorts that contain 11,590 guest rooms. On November 9, 2012, it acquired the 94-room Hotel Rex located in San Francisco, California.
Why Should Investors Buy DRH After The Recent Gain? Just Go Here and Find Out
About Impressive Penny Stocks
We are different here at Impressive Penny Stocks because we care about our subscribers. You can email us any time with questions, tips, or just to say hello. We are real people and we love to hear from our loyal subscribers.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ImpressivePennyStocks.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ImpressivePennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ImpressivePennyStocks’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ImpressivePennyStocks or an offer or solicitation to buy or sell any security. Neither the owner of ImpressivePennyStocks nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. ImpressivePennyStocks makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Read Full Disclaimer at: http://impressivepennystocks.com/disclaimer/#navigation
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)